Navigation Links
Cancer Drug Banned in England

Cancer drug Velcade has been banned in England because the Government’s drugs rationing watchdog, National Institute for Health and Clinical Excellence (NICE) has refused// to fund treatment, according to last night’s claims.

NICE has planned to announce next week that Velcade should not be offered on the NHS to treat multiple myeloma, a cancer of the bone marrow. Presently a course of Velcade has been estimated to cost between £9,000 and £18,000 and was already approved for use in Scotland in 1994.

Cancer sufferers and cancer charities criticized the decision by NICE, saying this was their latest attempt saving the Government money by rejecting drugs that increase life expectancy. Since June, NICE has refused to endorse five treatments including treatment for bowel cancer, leukaemia and breast cancer, as well as Alzheimer’s disease that would grant an extension to peoples’ lives suffering from these diseases.

As one cancer sufferer said: “Are they saying a Scottish life is worth more than an English life? “They are effectively saying to people with incurable diseases, ‘sit down in a darkened room and die’.”

NICE has refused to comment on next week’s announcement. A NICE spokesman said: “NICE’s expert advisers review all the evidence on cancer treatments to determine whether they add benefits for patients when compared to other treatments that are already available.

“The benefits that we assess include whether a drug extends life, and whether a drug improves patients’ quality of life.”

A Department of Health spokesman has refused to comment until the guidance was published.

SourceMedindia
NLA
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology: